24/7 Patient Assistance: 760-405-8205

Changhu Chen, MD

Radiation Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

specialties & services

  • Bio & Insurance Information
  • Education & Training


    Hunan Medical University

    Medical School


    Flushing Hospital Medical Center



    University of Pennsylvania Health System


  • Board Certifications

    American Board of Radiology - Radiation Oncology

  • Publications & Memberships

    Dr. Changhu Chen has contributed to 3 publications.

    Phase I study of vandetanib with radiation therapy with or without cisplatin in locally advanced head and neck squamous cell carcinoma.

    Papadimitrakopoulou, V. A.,Frank, S. J.,Cohen, E. W.,Hirsch, F. R.,Myers, J. N.,Heymach, J. V.,Lin, H.,Tran, H. T.,Chen, C. R.,Jimeno, A.,Nedzi, L.,Vasselli, J. R.,Low...; Head Neck. 2014 Oct 30.

    See more >>

    Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma.

    Ney, D. E.,Carlson, J. A.,Damek, D. M.,Gaspar, L. E.,Kavanagh, B. D.,Kleinschmidt-DeMasters, B. K.,Waziri, A. E.,Lillehei, K. O.,Reddy, K.,Chen, C.; J. Neurooncol.. 2014 Dec 20.

    See more >>

    Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiforme.

    Reddy, K.,Gaspar, L. E.,Kavanagh, B. D.,Chen, C.; J Med Imaging Radiat Oncol. 2014 Jul 01.

    See more >>